Last updated on April 20, 2014 at 21:20 EDT

Elsevier Appoints New Managing Director for Global Clinical Reference Group

April 25, 2012

PHILADELPHIA, Pennsylvania, April 25, 2012 /PRNewswire/ –

Jim Donohue to lead development of ClinicalKey, world’s first clinical insight engine

Elsevier [http://www.elsevier.com/wps/find/homepage.cws_home ], a world-leading
provider of scientific, technical and medical information products and services, has
appointed Jim Donohue as Managing Director of the Global Clinical Reference group in
Elsevier Health Sciences. In this new role, Donohue will report to Michael Hansen, CEO of
Elsevier Health Sciences.

One of Donohue’s first responsibilities is the commercial launch in April 2012 of
Elsevier’s ClinicalKey [http://www.clinicalkey.com ], the world’s first clinical insight
engine. ClinicalKey provides relevant, fast, trusted and comprehensive clinical answers
for clinicians.

“Jim brings much experience and valuable knowledge to his new role at Elsevier Health
Science,” said Michael Hansen, CEO of Elsevier Health Sciences. “Healthcare is
increasingly content and data-driven, and we are continuously looking for new and better
ways to put our world-leading medical reference content into the hands of clinicians
around the globe. Jim and his team will be spearheading those efforts.”

Jim Donohue started at Elsevier in 2006 as Managing Director for Science & Technology
books and then worked as the SVP/General Manager of MD Consult. Prior to Elsevier, Donohue
served as the Senior Vice President of Sales and Marketing for Augsburg Fortress, and
prior to that he founded and served as CEO of NetDoctor, the U.K.’s leading internet
health website and one of the fifth most visible websites in the U.K. at the time. Donohue
has also held vice president positions for EMEA at Times Mirror International Publishers,
and was vice president for marketing at Harper Collins.

Jim is based in Philadelphia. He has a B.A. in Political Science and Rhetoric from the
University of Arizona and an M.A. in Rhetoric and Public Address from the University of

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] andCell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Tom Reller
        Vice President, Global Corporate Relations, Elsevier

SOURCE Elsevier

Source: PR Newswire